WS
ANAC

Wedbush Securities’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Wedbush Securities’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-10,400
Closed -$254K – 796
2014
Q3 		$254K Hold
10,400
– – 0.04% 461
2014
Q2 		$184K Buy
+10,400
New +$167K 0.03% 551

Other funds holding ANAC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wedbush Securities's ANAC Position: Q4 2014 in Review

Wedbush Securities sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q4 2014, closing a stake of 10,400 shares — an estimated $254K sold.

Wedbush Securities first reported a position in ANAC in Q2 2014 and held it in 2 quarters. The position peaked at $254K in Q3 2014. 147 funds tracked by Wall St. Rank hold ANAC as of Q4 2014.

  • Wedbush Securities reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q4 2014 after selling out during the quarter.
  • Wedbush Securities sold 10,400 ANACOR PHARMACEUTICALS INC COM shares in Q4 2014, an estimated $254K.
  • Wedbush Securities first reported a position in ANACOR PHARMACEUTICALS INC COM in Q2 2014 and held it in 2 quarters.
  • Wedbush Securities's ANACOR PHARMACEUTICALS INC COM position peaked at $254K in Q3 2014.
  • 147 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q4 2014.

Based on Wedbush Securities's 13F filing for Q4 2014, filed 27 Jan 2015.